Literature DB >> 9605987

Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

G Menchaca1, L Padilla-Noriega, M Méndez-Toss, J F Contreras, F I Puerto, H Guiscafré, F Mota, I Herrera, R Cedillo, O Muñoz, R Ward, Y Hoshino, S López, C F Arias.   

Abstract

The relative contribution of the rotavirus surface proteins, VP4 and VP7, to the induction of homotypic as well as heterotypic neutralizing antibodies (NtAbs) in natural infections was studied. The NtAb titers of paired sera from 70 infants with serologically defined primary rotavirus infections were determined with a panel of rotavirus reassortants having one surface protein from a human rotavirus (serotypes G1 to G4 for VP7 and P1A and P1B for VP4) and the other surface protein from a heterologous animal rotavirus strain. A subset of 37 children were evaluated for epitope-specific antibodies to the two proteins by an epitope-blocking assay. The infants were found to seroconvert more frequently to VP4 than to VP7 by both methods, although the titers of the seroconverters were higher to VP7 than to VP4. Both proteins induced homotypic as well as heterotypic NtAbs. G1 VP7 frequently induced a response to both G1 and G3 VP7s, while G3 VP7 and P1A VP4 induced mostly homotypic responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605987      PMCID: PMC104520          DOI: 10.1128/CDLI.5.3.328-334.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  61 in total

1.  Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.

Authors:  P A Offit; R D Shaw; H B Greenberg
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

2.  Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.

Authors:  K Taniguchi; S Urasawa; T Urasawa
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

3.  Reassortant rotaviruses as potential live rotavirus vaccine candidates.

Authors:  K Midthun; H B Greenberg; Y Hoshino; A Z Kapikian; R G Wyatt; R M Chanock
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

4.  Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3.

Authors:  R D Shaw; D L Stoner-Ma; M K Estes; H B Greenberg
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

Review 5.  Rotavirus antigens.

Authors:  Y Hoshino; A Z Kapikian
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

6.  Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children.

Authors:  K Hjelt; P C Grauballe; A Paerregaard; O H Nielsen; P A Krasilnikoff
Journal:  J Med Virol       Date:  1987-01       Impact factor: 2.327

7.  Diverse serologic response to rotavirus infection of infants in a single epidemic.

Authors:  H F Clark; K T Dolan; P Horton-Slight; J Palmer; S A Plotkin
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

8.  Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections.

Authors:  M L O'Ryan; D O Matson; M K Estes; L K Pickering
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

9.  Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group.

Authors:  R L Ward; D I Bernstein
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

10.  Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

Authors:  S Chiba; T Yokoyama; S Nakata; Y Morita; T Urasawa; K Taniguchi; S Urasawa; T Nakao
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

View more
  5 in total

1.  Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.

Authors:  L Padilla-Noriega; M Méndez-Toss; G Menchaca; J F Contreras; P Romero-Guido; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; J Calva; M L Guerrero; B S Coulson; H B Greenberg; S López; C F Arias
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

2.  Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.

Authors:  S E Crawford; M K Estes; M Ciarlet; C Barone; C M O'Neal; J Cohen; M E Conner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Biochemical characterization of rotavirus receptors in MA104 cells.

Authors:  C A Guerrero; S Zárate; G Corkidi; S López; C F Arias
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Rotavirus diarrhea severity is related to the VP4 type in Mexican children.

Authors:  Felipe Mota-Hernández; Juan José Calva; Claudia Gutiérrez-Camacho; Sofía Villa-Contreras; Carlos F Arias; Luis Padilla-Noriega; Héctor Guiscafré-Gallardo; María de Lourdes Guerrero; Susana López; Onofre Muñoz; Juan F Contreras; Roberto Cedillo; Ismael Herrera; Fernando I Puerto
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.